A report by the insurance industry group AHIP (America’s Health Insurance Plans) suggests that physicians still have a way to go to be in compliance with the 2016 opioid prescribing and monitoring recommendations from the Centers for Disease Control and Prevention. And when it comes to instituting urine drug testing, they have a very long way to go indeed.
Drawing on prescribing data from member insurance providers, they found:
The group also published a detailed methodology so that other health insurance plans can implement similar monitoring within their own networks.